Ignite Creation Date:
2024-05-05 @ 6:40 PM
Last Modification Date:
2024-10-26 @ 9:36 AM
Study NCT ID:
NCT00527839
Status:
RECRUITING
Last Update Posted:
2023-10-19
First Post:
2007-09-07
Brief Title:
Hospital for Special Surgery Shoulder Arthroplasty Cohort
Sponsor:
Hospital for Special Surgery New York
Organization:
Hospital for Special Surgery New York
Study Overview
Official Title:
Prospective Evaluation of the Clinical and Economic Outcomes of Total Joint Replacement HSS Shoulder Arthroplasty Cohort
Status:
RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Total joint replacements are some of the most successful medical devices developed over the last fifty years They enable millions of people to remain ambulatory and pain free with minimal risk In 2002 over 200000 total hip replacements 350000 total knee replacements and 25000 total or partial shoulder replacements were performed in the United States HCUP data Future use will likely be even higher it is estimated that by the year 2020 the population 65 and over in developed countries will increase by 71 Existing studies do not provide adequate prospective data to evaluate long-term outcomes
HSS is a world leader in total joint replacement including total shoulder arthroplasty However there is no systematic follow-up or evaluation of patients who have their shoulders replaced here
The purpose of this study is to establish a prospective cohort of HSS total shoulder arthroplasty to evaluate predictors of outcome causes of failure and to allow ongoing evaluation of the results of our patients over time
HSS is a world leader in total joint replacement including total shoulder arthroplasty However there is no systematic follow-up or evaluation of patients who have their shoulders replaced here
The purpose of this study is to establish a prospective cohort of HSS total shoulder arthroplasty to evaluate predictors of outcome causes of failure and to allow ongoing evaluation of the results of our patients over time
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None